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Abstract We previously developed a model of acute cy-
closporine A (CsA)-induced vasomotor nephrotoxicity in
rabbits. As exogenous adenosine infusion mimics the
haemodynamic changes that characterize acute renal fail-
ure (ARF), we wanted to know whether adenosine was a
mediator in this model and whether an adenosine receptor
blocker could prevent the CsA-induced ARF. Group 1
were untreated controls. Group 2 received CsA (25 mg/kg
per day) for 5 days. Renal function parameters were mea-
sured, showing ARF in all animals compared to controls.
Theophylline (1 mg/kg i.v. bolus) was then administered
and renal function was reassessed. Theophylline signifi-
cantly reduced renal vascular resistance (–8%) and in-
creased renal blood flow (RBF) (+20%), glomerular fil-
tration rate (GFR) (+50%), filtration fraction (+24%) and
diuresis (+73%), suggesting that adenosine was involved
in the CsA-induced ARF. In group 3, theophylline 
(30 mg/kg per day) was given concomitantly with CsA
for 5 days. GFR was normalized, but theophylline did not
hinder the drop in RBF seen with CsA alone in group 2.
Microscopy observation of the kidneys showed that
chronic theophylline administration aggravated the mor-
phological changes induced by CsA alone. We conclude
that CsA administration for 5 days induced a vasomotor
nephropathy with an adenosine-mediated afferent arterio-
lar constriction which cannot be prevented by concomi-
tant theophylline administration.
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Introduction
Cyclosporine A (CsA) remains one of the most effective
immunosuppressive drugs used in the management of or-
gan transplantation and autoimmune diseases. However,
its use is still impaired by two major side effects, namely
systemic hypertension and nephrotoxicity [1, 2].
Chronic CsA nephrotoxicity has been widely studied.
Some studies were performed in the rabbit, a good animal
model showing close similarities with chronic CsA neph-
rotoxicity recorded in humans [3, 4, 5]. Because acute CsA
administration is now frequently used, acute CsA nephro-
toxicity needs closer attention. Indeed, Bisogno et al. [6]
recently reported the use of short-term (3 days), high dose
(15 and 30 mg/kg per day) intravenous CsA combined
with etoposide to treat recurrent or refractory solid tumours
in 18 children. Creatinine and/or urea were elevated in 14
of 32 courses of treatment (44%) [6], thus indicating a fall
in glomerular filtration rate (GFR).
Vasoactive substances mediate the acute renal vascu-
lar effects of CsA in both experimental models and hu-
mans. Among these mediators are angiotensin II, endo-
thelin or adenosine [7]. Guieu et al. demonstrated that
chronic administration of CsA to kidney transplant recip-
ients was accompanied by high plasma adenosine levels
[8]. This increase in adenosine plasma levels was attrib-
uted to CsA administration because: (1) CsA inhibited
adenosine uptake by red blood cells and increased its
half-life in vitro; (2) CsA blood levels were correlated
with adenosine plasma levels; (3) adenosine plasma lev-
els of non-CsA-treated kidney transplant recipients were
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in the same range as controls [8]. Likewise, Halimi et al.
demonstrated a CsA-induced increase in renal artery
adenosine concentration in rats, leading to renal vaso-
constriction by action on the adenosine A1 receptors [9].
Theophylline is an alkylxanthine adenosine receptor
antagonist commonly used in humans. It attenuates ra-
diocontrast-induced intrarenal vasoconstriction [10]. A
randomized study on 93 patients showed that four injec-
tions of theophylline (2.88 mg/kg) every 12 h totally pre-
vented the reduction in creatinine clearance induced by
low osmolarity radiocontrast products and partially re-
duced the acute renal failure (ARF) induced by high os-
molarity radiocontrast products [11]. More generally,
adenosine receptor antagonists were shown to have ben-
eficial effects in several experimental models of ARF,
both nephrotoxic and haemodynamic [12, 13, 14, 15].
Theophylline also was shown to improve acute CsA neph-
rotoxicity by inhibiting the CsA-induced contraction seen
in mesangial cells in culture and in isolated glomeruli [16,
17]. However, disappointing results were obtained when
theophylline was given to CsA-treated animals. Gerkens
and Smith found no effect of theophylline on the CsA-in-
duced renal function impairment in rats [18]. Moreover,
Churchill et al. found that not only did theophylline fail to
block the CsA-induced decreases in renal plasma flow
and GFR, if anything, it potentiated them [19].
Considering the overall conflicting results on the use
of theophylline in CsA-induced nephrotoxicity, addition-
al studies seem to be necessary.
We previously developed a rabbit model of acute CsA-
induced nephrotoxicity [20]: administration of 25 mg/kg
per day CsA for 5 days induced a significant decrease in
diuresis (V) which had a glomerular origin. The decrease
in GFR was associated with an increase in renal vascular
resistance (RVR) and a significant drop in renal blood
flow (RBF). Filtration fraction (FF) did not vary signifi-
cantly. The overall results suggest vasoconstriction of both
pre- and postglomerular arteries in this model.
The present study was designed to test the hypothesis
that endogenous adenosine mediates the reduction in
GFR seen in our model and if so, whether theophylline




Experiments were performed on 33 male New Zealand rabbits
weighing 2,874±530 g (range 2,390–3,420), housed in individual
cages and maintained on a standard diet (C15; Piétrement, France)
and tap water ad libitum. The animals were randomly allocated in-
to three groups (see Fig. 1).
In group 1, control animals (n=10) received no treatment be-
fore the day of the renal clearance studies.
All CsA-treated animals received subcutaneous injections 
of 25 mg/kg per day Sandimmun (cyclosporine A 50 mg/ml, 
0.25 ml/kg b.i.d.; kindly provided by Novartis Pharma S.A., Rueil-
Malmaison, France) for 5 days. In group 2, CsA/theophylline 
1-treated animals (n=11) received CsA. Then, on the day of the re-
nal clearance study (see Fig. 1), they were given 1 mg/kg of the-
ophylline dissolved in 5 ml of sterilized water for injection as an
i.v. bolus [as aminophylline (Sigma Chemicals, St Quentin Falla-
vier, France); aminophylline is theophylline complexed with ethyl-
enediamine, which dissociates to theophylline in body fluids]. This
group was designed to see whether adenosine was involved in the
acute renal failure seen with CsA administration for 5 days [20].
In group 3, CsA/theophylline 30-treated animals (n=12) were
treated with CsA and concomitantly infused through the marginal
ear vein with theophylline 30 mg/kg per day b.i.d. diluted in 10 ml
of saline. The dose of theophylline used in this group had been de-
fined from pre-study experiments (data not shown) in order to ob-
tain trough concentrations comparable with the peak concentra-
tions obtained after the acute administration in group 2. This
group was designed to see whether theophylline administered with
CsA could have a protective effect on the CsA-induced ARF.
Surgical preparation
All methods have been repeatedly described and thus will only be
summarized [7, 20]. Briefly, food was withheld 12 h before the
Fig. 1 Experimental protocol
in the three groups
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study with tap water remaining available ad libitum. Animals were
anaesthetized with sodium pentobarbital. The trachea was cannu-
lated to allow mechanical ventilation with fractional inspiratory
oxygen concentration 0.30. The left carotid artery and right jugu-
lar vein were catheterized for blood sampling, continuous moni-
toring of mean blood pressure (MBP) and solute infusion. The uri-
nary bladder was catheterized for urine collection. Body tempera-
ture was maintained in the range of physiological values for rab-
bits (~39°C) using a heated operating table.
Two millilitres of blood was then taken to measure CsA whole
blood trough levels and the animals received the last half-dose of
CsA. In group 3, 0.8 ml blood was taken to measure theophylline
trough serum concentrations. The animals then received the last
half-dose of theophylline (15 mg/kg) over 10 min. Twenty minutes
after completion of theophylline infusion, 0.8 ml of blood was
again taken to measure theophylline peak serum concentrations.
After completion of the surgical procedures, priming doses of
inulin and p-aminohippurate (PAH) were administered through the
jugular vein, with serum concentrations being maintained by a
continuous i.v. infusion at a rate of 0.1 ml/min. A sterile solution
of Ringer-mannitol containing NaCl (100 mM), KCl (6 mM),
NaHCO3− (50 mM) and mannitol (274 mM) was infused through
the jugular vein at a rate of 1 ml/min.
Approximately 30 min were spent in animal preparation, fol-
lowed by 60 min of equilibration.
Experimental procedures (Fig. 1)
In all 3 groups, each rabbit underwent an initial renal clearance
study of 30 min (period I), with blood sampling (5 ml) at the mid-
point. A sample of 0.9 ml whole blood was immediately used for
blood gas and haematocrit determination; the remainder was cen-
trifuged. The red blood cells were reconstituted in macromole-
cules (Plasmion; Bellon, Antony, France) and immediately re-
turned to the animal. Plasma and urine samples were stored at
–20°C for subsequent analysis.
In group 2, theophylline 1 mg/kg was then injected as an i.v.
bolus through the jugular vein. A blood sample of 0.8 ml was tak-
en 20 min after theophylline administration to measure its peak se-
rum concentrations. After a 40-min equilibration period, each rab-
bit underwent a second renal clearance study of 30 min (period II),
with another 5 ml blood sampling at the midpoint of the period.
The renal PAH extraction ratio (EPAH) was assessed at the end
of the experiment in all rabbits: following a small laparotomy, a
fine needle was inserted into the left renal vein and venous blood
was slowly withdrawn. Arterial blood was concomitantly taken
from the carotid artery. The left kidney was then removed for
blinded histological study (by EJ), and the animals were adminis-
tered a lethal i.v. dose of pentobarbital.
Analytical methods
Urine volume was calculated from the change in weight of pre-
weighed tubes without correction for specific gravity. The analysis
of sodium and proteins was performed using a Vitros 250/750 
(Ortho Diagnostics, Raritan, N.J., USA). Arterial blood gas deter-
minations were made using a pH/blood gas analyzer (Blood gas
system 168; Ciba-Corning Co., Melfield, Mass., USA).
Wright’s automatic anthrone [21] and the Bratton and Marshall
[22] methods were used for the determination of inulin and PAH
concentrations, respectively (Autoanalyzer II; Technicon Instru-
ment Corporation, Tarrytown, N.Y., USA).
Renal clearances of inulin (CIn) and PAH (CPAH) were calculat-
ed from standard formulae and used as indices of GFR and renal
plasma flow, respectively. Mean values of EPAH (0.86±0.03) were
not significantly different from 0.92 as previously determined in
our laboratory on eight untreated animals [15]. Thus, we used a
value of 0.92 to calculate RBF in the three groups.
EPAH, plasma/urine (P/U) inulin ratio, RBF, RVR, FF, fraction-
al excretion of sodium (FENa) and sodium excretion rate (UNaV)
were derived from standard equations as previously reported [20].
Whole blood cyclosporine concentrations were measured using
the enzyme multiplied immunoassay test (EMIT-Green Liquid;
Dade-Behring, Germany) on a Cobas Mira analyzer (Roche Diag-
nostic Systems, Meylan, France).
Theophylline was measured by immunofluorescence (TDX
Abbott, Rungis, France).
For light microscopy, fragments were stained with Masson’s
trichrome.
Statistical analysis
All data were expressed as mean ±SEM.
Inter-group comparisons were performed using the non-para-
metric Mann-Whitney U test, a Bonferroni adjustment being used
so as to assure an overall type I error rate of <0.05. Intra-group
comparisons within periods I and II in group 2 were performed us-
ing the non-parametric Wilcoxon signed-rank test; each animal




CsA whole blood trough concentrations were 808±92
and 1343±218 ng/ml (P<0.05) in groups 2 and 3, respec-
tively.
Effects of CsA administration (group 2, period I; 
Tables 1 and 2)
Compared with group 1, CsA administration in group 2
significantly decreased MBP, V, GFR, RBF, plasma Na,
UNaV and FENa with a concomitant increase of RVR. The
FF and P/U inulin ratio remained unchanged.
Effects of acute theophylline administration (1 mg/kg)
on CsA-pretreated rabbits (group 2, period II; 
Tables 1 and 2)
Theophylline peak serum concentrations were 13.0±
1.2 µmol/l (range 8.8–18.8) 20 min after administration.
There was a slight but significant decrease in protein
levels (–6.7±1.4%) from period I to period II, probably
as a result of repeated blood sampling. PaO2 decreased
slightly but significantly (–5.3±3%), no animal being
hypoxic.
MBP (+11±3%), urine flow rate (+73±14%), GFR
(+50±8%), RBF (+20±5%) and FF (+24±5%) all in-
creased significantly, whereas RVR significantly de-
creased (–8±3%). The P/U inulin ratio significantly in-
creased.
The i.v. infusion of theophylline induced a slight 
but significant rise in plasma Na (+1.5±0.4%) and a 
dramatic increase in UNaV (+443±160%) and FENa(+236±91%).
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Effects of chronic theophylline administration (30 mg/kg
per day) on CsA-treated rabbits (group 3; Tables 1 and 2)
Theophylline trough serum concentrations were 15.4±
1.9 µmol/l (range 8.3–25.4). Theophylline peak serum
concentrations were 133.1±7.8 µmol/l (range 88.3–
170.0) 20 min after administration.
CsA + theophylline treatment in group 3 was associ-
ated with a significant decrease in blood pH, plasma pro-
tein levels and haematocrit compared with untreated
controls (group 1, period I).
Compared with groups 1 and 2 (period I), concomi-
tant administration of theophylline with CsA induced a
significant rise in FF and an additional rise in RVR, al-
though not significant. Decreases of MBP, RBF and
FENa were not statistically different from those seen with
CsA administration alone.
Diuresis and UNaV were significantly higher than in
group 2 (period I), but did not reach the values of group 1.
The decrease in GFR seen with CsA alone (group 2,
period I) was blunted by concomitant theophylline ad-
ministration.
The P/U inulin ratio remained unchanged.
Microscopy observations (Fig. 2)
It is noteworthy that all renal structures in group 1 ap-
pear histologically normal.
The kidneys of 5 and 12 rabbits of groups 2 and 3, re-
spectively, were used for histological and cytological
study.
In group 2, one could see microvacuolization of the
proximal epithelial cells of the deep cortex and outer me-
dulla in all sections. The proximal tubule brush border was
preserved in the five kidneys studied. There were no
changes in the morphology of the glomeruli, arteries or in-
terstitial space which showed no lymphocyte infiltration.
Table 1 Values of physiological parameters in control animals
(group 1) and influence of intravenous infusion of theophylline
acutely (1 mg/kg, group 2, Theo 1) or theophylline chronically 
(30 mg/kg per day for 5 days, group 3, Theo 30) in cyclosporine
A-pretreated rabbits (25 mg/kg per day for 5 days, CsA). Values
are means ±SEM. Comparisons between groups were performed
using non-parametric Mann-Whitney U test, a Bonferroni adjust-
ment being used so as to assure an overall type I error rate of
<0.05. Intra-group comparisons within periods I and II in group 2
were performed using the Wilcoxon non-parametric test. (MBP
mean blood pressure, Hct haematocrit)
Parameter Group 1 Group 2 Group 3
Controls CsA 25 + Theo 1 CsA 25
Period I Period II + Theo 30
MBP (mmHg) 93.1±4.4 74.8±4.8* 82.4±4.6† 77.9±2.8#
pH 7.54±0.01 7.58±0.03 7.61±0.02 7.46±0.02#,¶
Proteins (g/l) 42.2±1.1 39.1±2.1 36.5±1.9† 36.2±1.2#
Hct (%) 34.9±1.0 34.5±0.9 34.0±1.0 32.1±0.6#
*P<0.05, group 2, period I versus group 1 ¶P<0.05, group 3 versus group 2, period I
#P<0.05, group 3 versus group 1 †P<0.05 for period II versus period I
Table 2 Values of renal function and renal haemodynamic param-
eters, water excretion and sodium handling in control animals
(group 1) and influence of intravenous infusion of theophylline
acutely (1 mg/kg, group 2, Theo 1) or theophylline chronically (30
mg/kg per day for 5 days, group 3, Theo 30) in cyclosporine A-
pretreated rabbits (25 mg/kg per day for 5 days, CsA 25). Values
are means ±SEM. Comparisons between groups were performed
using non-parametric Mann-Whitney U test, a Bonferroni adjust-
ment being used so as to assure an overall type I error rate of
<0.05. Intra-group comparisons within periods I and II in group 2
were performed using the Wilcoxon non-parametric test. (V urine
flow rate, GFR glomerular filtration rate, RBF renal blood flow,
FF filtration fraction, RVR renal vascular resistances, UNaV natri-
uresis, FENa fractional excretion of sodium)
Parameter Group 1 Group 2 Group 3
Controls CsA 25 + Theo 1 CsA 25
Period I Period II + Theo 30
V (ml/kg per min) 0.339±0.028 0.131±0.011* 0.215±0.010† 0.195±0.025#,¶
GFR (ml/kg per min) 5.29±0.37 2.96±0.46* 4.31±0.63† 4.52±0.68
P/U inulin ratio 0.068±0.009 0.050±0.005 0.059±0.008† 0.065±0.024
RBF (ml/kg per min) 28.1±2.6 17.0±2.4* 20.0±2.6† 16.0±3.5#
FF (%) 30.5±2.7 26.8±2.0 32.4±1.6† 59.9±11.5#,¶
RVR (mmHg/ml per kg per min) 3.61±0.29 5.15±0.57* 4.72±0.55† 9.24±2.15#
Plasma Na (mmol/l) 135.8±0.9 132.2±0.8* 134.2±0.6† 132.8±1.0
UNaV (µmol/kg per min) 44.63±4.85 3.98±1.18* 10.11±1.18† 11.20±2.86#,¶
FENa (%) 6.66±1.08 0.91±0.17* 1.94±0.31† 3.19±1.83#
*P<0.05 for group 2, period I versus group 1 ¶P<0.05 for group 3 versus group 2, period I
#P<0.05 for group 3 versus group 1 †P<0.05 for period II versus period I
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In group 3, one could see microvacuolization of the
proximal and distal tubules in all sections; one section
showed macrovacuolization as well. Shedding of the
proximal tubule brush border occurred in 4 of 12 kid-
neys. In one section, one could see two cortico-medul-
lary strands with interstitial fibrosis and lymphocyte in-
filtration surrounding some obsolescent glomeruli, and
tubules with a thickened basement membrane. Outside
these areas, glomeruli and interstitium were normal. In
one case, few obsolescent glomeruli were detected (3%).
Eight of the ten remaining observations showed dilated
glomerular capillaries with neutrophil and red blood cell
infiltration. There were no changes in the morphology of
the arteries and interstitium, which showed no lympho-
cyte infiltration.
Discussion
We previously demonstrated that adult rabbits given CsA
(25 mg/kg per day for 5 days) presented with acute vaso-
motor renal failure (decreased GFR and RBF with an in-
creased RVR; stable FF indicating both afferent and ef-
ferent vasoconstriction) [20].
In the present study, we infused theophylline, a non-
specific adenosine receptor antagonist, to test the hypoth-
esis that endogenous adenosine mediates the changes in
renal function parameters seen after treatment with CsA.
Acute administration of theophylline 1 mg/kg in group 2
(reaching micromolar plasma concentrations consistent
with adenosine receptor antagonism) increased GFR by
50% and significantly decreased RVR with a consequent
increase in renal perfusion in period II. The increase of
both FF and RBF indicated a predominant vasodilatation
of the afferent arteriole. Therefore, we can assume that
the CsA-induced ARF was associated with an adenosine-
mediated vasoconstriction of preglomerular arterioles.
Even though two in vivo studies failed to disclose a role
of adenosine in the CsA nephrotoxicity in the rat [18, 19],
our results agree with the beneficial effects of adenosine
receptor antagonists, including theophylline, found in
other animal models of experimental acute renal failure
as well as in humans (hypoxemia, endotoxin administra-
tion) [10, 11, 13, 15, 23, 24]. These results also fit well
with data obtained in vitro showing that theophylline
could ameliorate acute CsA nephrotoxicity by inhibiting
the mesangial cell contraction elicited with CsA [17].
The preglomerular vasoconstrictor effect of adenosine
could be explained by an adenosine-angiotensin II inter-
action in the kidney [25, 26], as we have previously re-
ported beneficial effects of perindopril, an angiotensin
converting enzyme inhibitor, in this model [7]. This ef-
fect could be mediated by A1 receptors, because adeno-
sine A1 receptor stimulation in the isolated perfused kid-
ney leads to a decrease in GFR and FF, consistent with
afferent arteriolar vasoconstriction [27, 28].
The increase in urine flow rate seen after acute the-
ophylline administration was due to both the increase in
GFR and an inhibition of tubular water reabsorption
since the P/U inulin ratio increased. Theophylline also
induced a dramatic increase in both UNaV (+443%) and
FENa (+236%). Indeed, adenosine antagonists have been
shown to induce diuresis and natriuresis even in the ab-
sence of detectable increases in RBF or GFR. The local-
ization of A1 receptors in rabbit cortical collecting tu-
bules would support the assumption of a direct receptor-
mediated tubular effect [29]. Peripheral activation of ar-
terial chemoreceptors by adenosine could also lead to an-
tinatriuresis by activation of the sympathetic nervous
system with increased renal nerve activity. Therefore, the
effect of systemically administered theophylline could
also reflect an interaction with arterial chemoreceptors
[30]. Finally, we cannot exclude that the natriuretic ef-
fect of theophylline could be at least in part pressure-re-
lated, since theophylline administration led to a slight
(+11%) but significant increase in MBP.
Fig. 2a,b Light microscopy of kidney sections. a Rabbit from
group 2 treated with CsA (25 mg/kg per day s.c.) for 5 days and
theophylline (1 mg/kg as an i.v. bolus). Note the intense cytoplas-
mic microvacuolization of the proximal tubule epithelial cells (ar-
rows). b Rabbit from group 3 treated with CsA (25 mg/kg per day
s.c.) and theophylline (30 mg/kg per day i.v.) for 5 days. Note the
central area with dilated tubules (big arrows), lymphocyte infiltra-
tion (small arrows) and mild interstitial fibrosis. (Masson’s tri-
chrome; a, b ×230)
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The overall results indicate that acute CsA nephrotox-
icity is mediated at least partly via adenosine. Therefore,
we wanted to see whether theophylline, a drug common-
ly used in clinical practice, administered concomitantly
with CsA could prevent the CsA-induced ARF.
Administration of theophylline 30 mg/kg per day with
CsA was associated with GFR normalization and an in-
crease in FF, but failed to block the CsA-induced de-
creases in RBF and FENa. It even potentiated renal vaso-
constriction as seen by an increased RVR. These results
suggest that chronic administration of theophylline elic-
ited a predominant efferent vasoconstriction, thus pro-
moting enhanced FF and maintaining GFR despite a de-
creased RBF.
The discrepancy in haemodynamic and histological
results between acute and chronic administration of the-
ophylline could be explained by the significant rise in
CsA blood levels, by 66%, observed in group 3. We hy-
pothesize that this elevation in CsA blood levels could
be the consequence of an action of theophylline on the
hepatic metabolism of CsA by cytochrome P450 [18,
31], as has been seen recently in a renal transplant pa-
tient treated with theophylline and tacrolimus [32]. The
increased efferent renal vasoconstriction could also lead
to a decrease in CsA urinary clearance, explaining the el-
evated CsA blood levels.
The lack of a protective effect of theophylline on the
CsA-induced nephrotoxicity could also be explained by
the fact that high theophylline dosage has been associat-
ed with an augmented release of catecholamines from
the sympatho-adrenal system, leading to an α-agonist-
mediated renal vasoconstriction [33]. However, this did
not seem to be the case in our study because the heart
rates were not significantly modified (data not shown,
P=0.14).
The mechanism of acute CsA-induced renal vasocon-
striction is a complex process involving a cascade of ac-
tivation of endogenous mediating factors in afferent as
well as efferent arterioles. We previously published on
the major role of endothelin and angiotensin II in this
model [7] and prostaglandins and nitric oxide are cur-
rently under evaluation.
The present results are further evidence to suggest
that the changes in renal function caused by CsA are also
partly due to the mediation of adenosine. However, de-
spite its apparent beneficial effect when used acutely,
theophylline should not be used concomitantly with CsA
for a long period of time in view of its effects on CsA
hepatic metabolism and on renal scarring.
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